Please login to the form below

Not currently logged in
Email:
Password:

Promimic appoints CEO

Magnus Larsson succeeds Ulf Brogren at the Swedish firm

Promimic Magnus LarssonGothenburg, Sweden-based Prominic, part of life science investment company Karolinska Development, has appointed Magnus Larsson as its new chief executive officer.

Larsson joins the nano-materials developer from Dentsply Sirona Implants, where he was most recently director for global market development.

He brings over 15 years of sales and marketing leadership experience in the international dental implant industry, including three years at Nobel Biocare as country manager for its Swedish business.

Tord Lendau, chairman of the board at Promimic, said: “We are pleased to welcome Magnus Larsson to the company as chief executive officer.

“Magnus brings valuable global leadership experience and a wide network from his time in the dental implant industry.”

Meanwhile, Promimic's former chief executive Ulf Brogren is relocating to the US to lead the launch of the company's North America sales operations from Austin, Texas.

Lendau added: “With this appointment and the launch of Promimic under Mr Brogren's leadership, we are now in much better position to meet our strategic commitment to our customers in North America and build our business in this important market.”

1st February 2017

From: Sales

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics